SCHEMBL1376360

SCHEMBL1376360

Cc1cc(Nc2ncccc2C=O)no1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ PDE5A O76074 1/20 0.41
▸ RAB9A P51151 7/20 0.41
▸ NPC1 O15118 5/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ TDP2 O95551 1/20 0.40
▸ TRIM24 O15164 1/20 0.39
▸ TRIM33 Q9UPN9 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HPGD P15428 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ TRPM8 Q7Z2W7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL590287 0.80 TRIM24 (0.36) POLBSMN1; SMN2TRIM24TRIM33ALDH1A1
SCHEMBL1373504 0.74 RAB9A (0.48) POLBL3MBTL1RAB9ANPC1SMN1; SMN2
SCHEMBL10835241 0.73 RAB9A (0.56) POLBL3MBTL1RAB9ANPC1SMN1; SMN2
SCHEMBL9402355 0.72 GRM4 (0.52) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL16627415 0.72 GAA (0.56) POLBRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL16627413 0.72 RAB9A (0.62) RAB9ANPC1SMN1; SMN2TRIM24TRIM33
SCHEMBL16627420 0.72 ALDH1A1 (0.44) RAB9ANPC1SMN1; SMN2TRIM24TRIM33
SCHEMBL6642616 0.71 TRIM24 (0.39) L3MBTL1RAB9ANPC1SMN1; SMN2TRIM24
SCHEMBL31023942 0.71 TRIM24 (0.52) L3MBTL1RAB9ANPC1SMN1; SMN2TRIM24
SCHEMBL1376029 0.71 TRIM24 (0.52) L3MBTL1RAB9ANPC1SMN1; SMN2TRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2394995-B1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES KUMIAI CHEMICAL INDUSTRY CO (JP) 2014-01-15 — — EP disclosed
US-8334236-B2 Ring-fused 2-pyridone derivatives and herbicides KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2012-12-18 — — US disclosed
EP-2394995-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES Kumiai Chemical Industry CO., LTD. (JP) 2011-12-14 — — EP disclosed
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2011-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES CBR3, CBR1, CHRM1 POLB 3238/4885L3MBTL1 944/4885PDE5A 2595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback